- Home
- MOGU vs EDSA Comparison
MOGU vs EDSA Comparison
Compare MOGU & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- EDSA
- Stock Information
- Founded
- MOGU 2011
- EDSA 2015
- Country
- MOGU China
- EDSA Canada
- Employees
- MOGU N/A
- EDSA N/A
- Industry
- MOGU Business Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- EDSA Health Care
- Exchange
- MOGU Nasdaq
- EDSA Nasdaq
- Market Cap
- MOGU 16.2M
- EDSA 13.8M
- IPO Year
- MOGU 2018
- EDSA N/A
- Fundamental
- Price
- MOGU $2.11
- EDSA $4.05
- Analyst Decision
- MOGU
- EDSA Strong Buy
- Analyst Count
- MOGU 0
- EDSA 2
- Target Price
- MOGU N/A
- EDSA $39.00
- AVG Volume (30 Days)
- MOGU 8.9K
- EDSA 13.1K
- Earning Date
- MOGU 07-09-2024
- EDSA 08-09-2024
- Dividend Yield
- MOGU N/A
- EDSA N/A
- EPS Growth
- MOGU N/A
- EDSA N/A
- EPS
- MOGU N/A
- EDSA N/A
- Revenue
- MOGU $22,206,772.00
- EDSA N/A
- Revenue This Year
- MOGU N/A
- EDSA N/A
- Revenue Next Year
- MOGU N/A
- EDSA N/A
- P/E Ratio
- MOGU N/A
- EDSA N/A
- Revenue Growth
- MOGU N/A
- EDSA N/A
- 52 Week Low
- MOGU $1.62
- EDSA $2.50
- 52 Week High
- MOGU $3.58
- EDSA $6.46
- Technical
- Relative Strength Index (RSI)
- MOGU 46.13
- EDSA 38.30
- Support Level
- MOGU $2.04
- EDSA $4.00
- Resistance Level
- MOGU $2.50
- EDSA $4.44
- Average True Range (ATR)
- MOGU 0.26
- EDSA 0.25
- MACD
- MOGU -0.02
- EDSA -0.03
- Stochastic Oscillator
- MOGU 11.21
- EDSA 4.77
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.